Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China

16-Jun-2012 | General Article (Non-News)

GBI Research has released its latest research “Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets”, which provides insights into drivers, barriers and trends in the outsourcing of drug development tin the global pharmaceutical and biotechnology industry. The report profiles top 20 contract research organization in Asia-Pacific and provides business overview, business snapshot and the list of alliances made in the period 2005 to 2010
 In-depth analysis of the report is based on propriety databases, primary and secondary research and in-house analysis by GBI Research’s team of experts.
The scope of this report includes -
 - Analysis of drivers and barriers in the outsourcing of drug development processes
 - Analysis of different functional models in the global CRO industry
 - Analysis of key reasons for the pharmaceutical industry to outsource drug development
 Reasons to buy
The report will enhance your decision making capability. It will allow you to -
 - Identify the top 20 contract research organizations in Asia-pacific
 - Identify major international pharmaceutical companies who have made alliances with the Asia-Pacific CROs
 - Understand the service offerings of major CROs in the Asia-Pacific
 1 Table of Contents
 1 Table of Contents 4
 1.1 List of Tables 8
 1.2 List of Figures 9
 2 Contract Research Outsourcing – Introduction 11
 2.1 GBI Research Report Guidance 11
 3 Top 20 Contract Research Organizations – Overview 12
 3.1 Global Contract Research Outsourcing 12
 3.2 The Clinical Research Process 13
 3.3 Outsourcing of Clinical Research and Trial Processes 15
 3.3.1 Clinical Research Outsourcing Perceived to be a Solution to Problems Such as Rising Costs or Low Productivity 15
 3.3.2 Strategic Outsourcing Improves Value for Outsourcing Companies 15
 3.4 Key Reasons for Outsourcing to Contract Research Organizations 16
 3.4.1 Gaining Cost Reductions is a Key Reason for Contract Research Outsourcing 17
 3.4.2 CROs Engaged in Reducing Time to Market in Order to Achieve a Competitive Edge 17
 3.4.3 Data Management Allows Biopharmaceutical Companies to Focus on Core Competencies 18
 3.4.4 Evolving Risk Sharing Agreements Encourage Biopharmaceutical Companies to Increase Contract Research Outsourcing 18
 3.4.5 CROs Help to Improve Clinical Research Quality 18
 3.4.6 Small and Medium Biopharmaceutical Companies can Capitalize on the Resources of CROs 19
 3.4.7 Biopharmaceutical Companies Benefit from New Technologies 19
 4 Contract Research Outsourcing – Geographical Landscape 20
 4.1 Emerging Regions in the Global Contract Research Outsourcing Market 21
 4.1.1 Latin America 21
 4.1.2 Central and Eastern Europe (CEE) 21
 4.1.3 India 22
 4.1.4 China 23
 4.2 Why India and China? 24
 4.2.1 Availability of Skilled Manpower 24
 4.2.2 Scale of Available Resources for Clinical Development 26
 4.2.3 Improved IP Protection in India and China 26
 4.2.4 Government Support for the Drug Discovery Development 27
 4.2.5 Risk Sharing Agreements: A Step Forward by Indian and Chinese Companies 28
 For more information kindly visit :
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Follow us on twitter:!/Sandhya3B
 Our Blogs:

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Login to Submit Email

Author Info

Tag Cloud


More Releases


Add a Comment